↑ Rising
Business
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
Eli Lilly moves close to a $2.8 billion acquisition of psychedelic pioneer AtaiBeckley, sparking a sharp rally in ATAI shares.
1 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly moves close to a $2.8 billion acquisition of psychedelic pioneer AtaiBeckley, sparking a sharp rally in ATAI shares.